Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 4;13(8):e073776.
doi: 10.1136/bmjopen-2023-073776.

Host-microbiota relationship in the pathophysiology of aseptic abscess syndrome: protocol for a multicentre case-control study (ABSCESSBIOT)

Ludovic Trefond  1   2 , Elisabeth Billard  3 , Bruno Pereira  4 , Damien Richard  5 , Emilie Vazeille  3 , Richard Bonnet  3   6 , Nicolas Barnich  3 , Marc Andre  3   2 ; Aseptic Abscess Syndrome physicians
Collaborators, Affiliations

Host-microbiota relationship in the pathophysiology of aseptic abscess syndrome: protocol for a multicentre case-control study (ABSCESSBIOT)

Ludovic Trefond et al. BMJ Open. .

Abstract

Introduction: Aseptic abscess (AA) syndrome is a rare disease whose pathophysiology is unknown. It is often associated with inflammatory bowel disease and characterised by sterile inflammation with collections of neutrophils affecting several organs, especially the spleen. Microbiota are known to influence local and systemic immune responses, and both gut and oral microbiota perturbations have been reported in diseases associated with AA syndrome. However, interactions between these factors have never been studied in AA syndrome. The purpose of this translational case-control study (ABSCESSBIOT) is to investigate gut and/or oral microbiota in patients with AA syndrome compared with healthy controls. Moreover, microbiota associated metabolites quantification and Treg/Th17 balance characterisation will give a mechanistic insight on how microbiota may be involved in the pathophysiology of AA syndrome.

Methods and analysis: This French multicentre case-control study including 30 French centres (University hospital or regional hospital) aims to prospectively enrol 30 patients with AA syndrome with 30 matched controls and to analyse microbiota profiling (in stools and saliva), microbial metabolites quantification in stools and circulating CD4+ T cell populations.

Ethics and dissemination: This study protocol was reviewed and approved by an independent French regional review board (n° 2017-A03499-44, Comité de Protection des Personnes Ile de France 1) on 10 October 2022, and declared to the competent French authority (Agence Nationale de Sécurité du Médicament et des produits de santé, France). Oral and written informed consent will be obtained from each included patient and the control participant. Study results will be reported to the scientific community at conferences and in peer-reviewed scientific journals.

Trial registration number: Clinical Trials web-based platform (NCT05537909).

Keywords: IMMUNOLOGY; INTERNAL MEDICINE; Inflammatory bowel disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Design of the ABSCESSBIOT study.
See this image and copyright information in PMC

References

    1. André M, Aumaitre O, Marcheix JC, et al. Unexplained sterile systemic abscesses in Crohn's disease: aseptic abscesses as a new entity. Am J Gastroenterol 1995;90:1183–4. - PubMed
    1. Trefond L, Frances C, Costedoat-Chalumeau N, et al. Aseptic abscess syndrome: clinical characteristics, associated diseases, and up to 30 years' evolution data on a 71-patient series. J Clin Med 2022;11. 10.3390/jcm11133669 - DOI - PMC - PubMed
    1. Guettrot-Imbert G, Haroche J, Grimon G, et al. F-18 FDG-PET/CT in aseptic abscesses with recurrent febrile abdominal pain. Scand J Gastroenterol 2011;46:577–82. 10.3109/00365521.2010.539254 - DOI - PubMed
    1. Kémény JL, André M, Charlotte F, et al. Aseptic abscesses in eight patients with Cryptogenic inflammatory bowel disease. Ann Pathol 1999;19:294–8. - PubMed
    1. Bardy A, Guettrot-Imbert G, Aumaître O, et al. Efficacy of Il-1Β blockade in refractory aseptic abscesses syndrome. Mod Rheumatol 2014;24:217–9. 10.3109/14397595.2013.852835 - DOI - PubMed

Publication types

Associated data